Dr. Sulaiman Al Habib Medical S vs DaVita Inc.
A head-to-head of Dr. Sulaiman Al Habib Medical S (4013) and DaVita Inc. (DVA) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | 4013 | DVA |
|---|---|---|
| Market Cap | 75.29B SAR | $15.21B |
| P/E (TTM) | 31.36 | 21.98 |
| Forward P/E | 28.64 | 11.63 |
| P/S | 5.45 | 0.91 |
| P/B | 9.47 | 15.64 |
| EV/EBITDA | 26.07 | 8.90 |
| Dividend Yield | 1.85% | — |
| Profit Margin | 16.79% | 5.65% |
| Gross Margin | 30.69% | 32.25% |
| Operating Margin | 19.26% | 14.74% |
| Revenue Growth (YoY) | +8.80% | +5.96% |
| FCF Yield | 0.81% | 12.00% |
| Debt / Equity | 113.79 | 1013.79 |
| Current Ratio | 1.14 | 1.42 |
Which is better: Dr. Sulaiman Al Habib Medical S or DaVita Inc.?
- ✓Larger by market cap: Dr. Sulaiman Al Habib Medical S
- ✓Cheaper valuation (lower P/E): DaVita Inc.
- ✓More profitable (net margin): Dr. Sulaiman Al Habib Medical S
- ✓Faster revenue growth: Dr. Sulaiman Al Habib Medical S
- ✓Higher free-cash-flow yield: DaVita Inc.
Across 12 available metrics, DaVita Inc. leads 7–5.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
Compare Dr. Sulaiman Al Habib Medical S with others
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.